Exact Sciences Corp
—- Market cap
- —
- Debt
- +$2.85B
- Cash
- −$964.71M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: EXAS stock price vs CWK: inconclusive — current versus $5.30 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CWK's multiple
Implied fair value · at EXAS's multiple
Needs EXAS P/S.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EXAS FY 2025 (ended Dec 31, 2025) · CWK FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 54% equity / 46% debt · EV / Revenue 0.50x · EV / EBITDA 9.77x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
EXACT SCIENCES CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Cushman & Wakefield Ltd. · implied price per share
Bear
$1.12
Base
$2.79
Bull
$4.98
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.19x
1.41x
Net debt / EBITDA
Leverage against operating earnings
35.68x
3.71x
Cash and equivalents
Liquid reserves on the balance sheet
$964.71M
$784.20M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Guardant Health, Inc.
EXAS vs GH
Natera, Inc.
EXAS vs NTRA
NEOGENOMICS INC
EXAS vs NEO
OPKO HEALTH, INC.
EXAS vs OPK
LABCORP HOLDINGS INC.
EXAS vs LH
QUEST DIAGNOSTICS INC
EXAS vs DGX
JONES LANG LASALLE INC
EXAS vs JLL
CBRE GROUP, INC.
EXAS vs CBRE
Marcus & Millichap, Inc.
EXAS vs MMI
COSTAR GROUP, INC.
EXAS vs CSGP
RMR GROUP INC.
EXAS vs RMR
$2.85B
$2.75B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.